Özet:

Over Cancer is the fifth most common cancer in women, but is ranked first among the causes of death related to gynecological cancer. Our study aims to retrospective assess the health of patients treated due to over cancer, survival results and observed side effects related to treatment. Method and Requirements: In our study from January 2010 to January 2020 Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital Medical Oncology Clinic for the purpose of diagnosis and treatment followed over 160 cancer-related medical records have been retrospective examined from the system notes and files. Our study included patients aged 18 and over who were diagnosed with over cancer. The incidents were detailed according to the age average, over cancer histopathological types, the diagnosis stage, the side effects that they received related to chemotherapy, progressive survival (PFS) and general survival (GS) periods. For the calculation of the duration of life, Kaplan-Meier analysis was used. The average age of 160 patients in the study was 61 ± 11. According to the histopathological subgroups, the most frequent (80.6) serous epithelial over cancer was detected. During the diagnosis, the phase distribution was studied and the most cases were diagnosed in Phase III. The most common side effects associated with chemotherapy was alopecia (100%) while the incidence of side effects other than alopecia was 51.2%. In 48.8 percent of cases, nickness was estimated; median progressive survival was 19.1 months; in the entire group, overall survival was estimated at 89.9 months. In cases of dose reduction, the overall survival was significantly low (p<0,05). CONTRACT and RESULT: Our study is similar to other studies in terms of the age of the events, the diagnosis stage of the disease, chemotherapy side effects, survival rates. The negative effect of dose reduction on overall survival is similar to most studies, but the need for new research on this subject is highlighted.

Anahtar Kelimeler: